The following pages link to Peter F. Thall (Q395985):
Displayed 17 items.
- Approximate Bayesian Evaluation of Multiple Treatment Effects (Q4668402) (← links)
- Practical Bayesian Guidelines for Phase IIB Clinical Trials (Q4842831) (← links)
- Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer (Q4916481) (← links)
- Rejoinder (Q4916484) (← links)
- Statistical Remedies for Medical Researchers (Q5106662) (← links)
- An adaptive trial design to optimize dose‐schedule regimes with delayed outcomes (Q5128802) (← links)
- A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III (Q5214489) (← links)
- Rejoinder to “A hybrid phase I‐II/III clinical trial design allowing dose reoptimization in phase III” (Q5214492) (← links)
- Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity (Q5367394) (← links)
- Ethical issues in oncology biostatistics (Q5424159) (← links)
- A Geometric Approach to Comparing Treatments for Rapidly Fatal Diseases (Q5473225) (← links)
- Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial (Q5474399) (← links)
- Determining a Maximum‐Tolerated Schedule of a Cytotoxic Agent (Q5714615) (← links)
- BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival Comparisons (Q5857110) (← links)
- Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen (Q5901511) (← links)
- Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers (Q6055528) (← links)
- Robust adaptive incorporation of historical control data in a randomized trial of external cooling to treat septic shock (Q6201428) (← links)